Buprenorphine
NDC 0093-3239, Buprenorphine, patch, extended release, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-3239
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204937
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE7.5 ug/h
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-3239-40 | 00093323940 | 4 POUCH in 1 CARTON (0093-3239-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/36995ce3-b515-447b-baa9-aa14f84060d8NADAC price for package 00093323940
GET /v1/drugs/nadac/00093323940
Use it
Look up 0093-3239 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-3239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.